Dolby Laboratories (NYSE:DLB) Updates Q1 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLBGet Free Report) issued an update on its first quarter 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.960-1.110 for the period, compared to the consensus earnings per share estimate of 0.700. The company issued revenue guidance of $330.0 million-$360.0 million, compared to the consensus revenue estimate of $307.9 million. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.

Dolby Laboratories Stock Performance

Shares of DLB traded down $0.42 on Tuesday, hitting $70.93. 416,799 shares of the stock traded hands, compared to its average volume of 396,175. The company has a market capitalization of $6.76 billion, a PE ratio of 32.38 and a beta of 0.98. The business has a 50 day simple moving average of $73.66 and a 200 day simple moving average of $76.09. Dolby Laboratories has a one year low of $66.35 and a one year high of $90.06.

Dolby Laboratories announced that its Board of Directors has authorized a stock buyback plan on Wednesday, August 7th that permits the company to buyback $350.00 million in shares. This buyback authorization permits the electronics maker to reacquire up to 5% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s leadership believes its shares are undervalued.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. StockNews.com upgraded shares of Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a report on Monday. Barrington Research restated an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a report on Friday, September 20th.

View Our Latest Report on Dolby Laboratories

Insider Buying and Selling

In other news, CEO Kevin J. Yeaman sold 28,512 shares of Dolby Laboratories stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the transaction, the chief executive officer now owns 83,721 shares in the company, valued at $6,205,400.52. This trade represents a 25.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 39.54% of the stock is currently owned by corporate insiders.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Stories

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.